Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Journal of the National Cancer Institute|May 1, 2016
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the OthersJohn M S Bartlett, Jane Bayani, Andrea Marshall, et al.Health Technology Assessment (Winchester, England)|September 4, 2020
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCTHelena Earl, Louise Hiller, Anne-Laure Vallier, et al.European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|July 20, 2017
Aiming for a holistic integrated service for men diagnosed with prostate cancer - Definitions of standards and skill sets for nurses and allied healthcare professionalsAlastair D Lamb, Sue Thompson, Netty Kinsella, et al.Cell|December 4, 2003
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancerLuke Hughes-Davies, David Huntsman, Margarida Ruas, et al.Lancet (London, England)|June 11, 2019
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trialHelena M Earl, Louise Hiller, Anne-Laure Vallier, et al.Bone & Joint Open|February 12, 2024
Radiological outcomes following surgical fixation with wires versus moulded cast for patients with a dorsally displaced fracture of the distal radius: a radiographic analysis from the DRAFFT2 trialCaroline E Plant, Alexander Ooms, Jonathan A Cook, et al.The Bone & Joint Journal|May 31, 2026
Infection following foot and ankle surgery : a subanalysis of data captured from the UK Foot and Ankle Thromboembolism (FATE) auditJenna Shepherd, Lyndon Mason, Linzy Houchen-Wolloff, et al.The Bone & Joint Journal|October 31, 2024
UK Foot and Ankle Thromboembolism (UK-FATE)Jitendra Mangwani, Linzy Houchen-Wolloff, Karan Malhotra, et al.Pageof 9